GoddardDSHornBNMcCalmontTH. Clinical update on graft-versus-host disease in children. Semin Cutan Med Surg2010; 29: 92–105.
2.
IbrahimRBAbidiMHCroninSM. Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant2009; 15: 395–405.
AndreeHHilgendorfILeithaeuserM. Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD. Bone Marrow Transplant2008; 42: 541–546.
5.
WolffDGerbitzAAyukF. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant2010; 16: 1611–1628.
6.
DignanFLClarkAAmroliaP. Diagnosis and management of acute graft-versus-host disease. Haemato-oncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation. Br J Haematol2012; 158: 30–45.
7.
DignanFLAmroliaPClarkA. Diagnosis and management of chronic graft-versus-host disease. Haemato-oncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation. Br J Haematol2012; 158: 46–61.
8.
FedorakRNBistritzL. Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide. Adv Drug Deliv Rev2005; 57: 303–316.
9.
EdsbäckerSAnderssonT. Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease. Clin Pharmacokinet2004; 43: 803–821.
10.
Scientific Leaflet Entocort (in Dutch), http://www.bcfi.be/ (2011, accessed 21 June 2013).
ThackerDPatelADoddsK. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg2010; 89: 837–842.
13.
VillanuevaFNPérez-SimónJASilvaFF. Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD). Biol Blood Marrow Transplant2006; 12: 936–941.
